Summary & Overview
HCPCS J1040: Injection, Methylprednisolone Acetate, 80 mg
HCPCS Level II code J1040 denotes an injection of methylprednisolone acetate, 80 mg, a commonly utilized corticosteroid preparation for inflammatory and musculoskeletal conditions. Nationally, accurate coding of injectable corticosteroids affects claims processing, appropriate benefit application, and clinical documentation for ambulatory and outpatient procedures.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage considerations and billing context across major payers, typical sites of service where J1040 is applied, and common clinical scenarios in which methylprednisolone acetate injections are administered.
The publication provides benchmarks and policy-relevant details such as coverage nuances, billing best practices, and documentation expectations tied to injectable corticosteroids. It also outlines common modifiers and coding relationships where available. Data not provided in the input (for example, payer-specific reimbursement rates, associated ICD-10 diagnoses, and taxonomy mappings) are noted as unavailable. The content is intended for national audiences involved in billing, revenue cycle, and clinical operations seeking concise, code-specific guidance on HCPCS Level II code J1040.
Billing Code Overview
HCPCS Level II code J1040 represents an injection of methylprednisolone acetate, 80 mg. This code describes a single-dose administration of a corticosteroid formulation commonly used for anti-inflammatory and immunosuppressive purposes.
-
Service type: Injectable corticosteroid administration
-
Typical site of service: Outpatient clinics, physician offices, ambulatory surgical centers, and other outpatient settings where intra-articular or soft-tissue steroid injections are performed. If an alternate site is used, detail is not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with focal musculoskeletal pain from osteoarthritis, bursitis, tendinopathy, or an acute inflammatory flare who presents to an orthopedic clinic, sports medicine practice, pain management clinic, or an ambulatory surgery center. After history, focused physical exam, and review of prior imaging (plain radiographs, ultrasound, or MRI if available), the clinician discusses risks and benefits of a corticosteroid injection. Informed consent is obtained. The patient is positioned at the procedure table; the intended anatomic site (for example, a glenohumeral joint, subacromial space, knee joint, trochanteric bursa, or epidural space when appropriate) is prepped with antiseptic. Local anesthetic may be administered for skin and soft tissue anesthesia. Using landmark or image guidance (ultrasound or fluoroscopy), the clinician injects J1040 (methylprednisolone acetate, 80 mg) into the targeted site, often combined with local anesthetic per protocol. The patient is observed briefly for immediate adverse reaction and given post‑procedure instructions (activity modification, watch for infection or systemic steroid effects). Documentation includes indication, site, laterality, amount and specific agent J1040, technique (image guidance if used), any concurrent medications administered, consent, and post‑procedure status.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 |